Liver abscess in advanced hepatocellular carcinoma after atezolizumab plus bevacizumab treatment: A case report

Hepatocellular carcinoma (HCC) is the sixth most common type of cancer globally. Since 2020, combination treatment with atezolizumab and bevacizumab were approved in patients with unresectable HCC in Japan, and atezolizumab plus bevacizumab is the first-line treatment for unresectable HCC. PATIENT C...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Keisuke, Ozono, Yoshinori, Uchiyama, Naomi, Hatada, Hiroshi, Nakamura, Kenichi, Komaki, Yuri, Iwakiri, Hisayoshi, Hasuike, Satoru, Nagata, Kenji, Sato, Yuichiro, Kawakami, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439774/
https://www.ncbi.nlm.nih.gov/pubmed/36107543
http://dx.doi.org/10.1097/MD.0000000000030486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439774/
https://www.ncbi.nlm.nih.gov/pubmed/36107543
http://dx.doi.org/10.1097/MD.0000000000030486

Ejemplares similares